Sustained Release of Tacrolimus Embedded in a Mixed Thermosensitive Hydrogel for Improving Functional Recovery of Injured Peripheral Nerves in Extremities
Open Access
- 3 February 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 508
Abstract
Vascularized composite allotransplantation is an emerging strategy for the reconstruction of unique defects such as amputated limbs that cannot be repaired with autologous tissues. In order to ensure the function of transplanted limbs, the functional recovery of the anastomosed peripheral nerves must be confirmed. The immunosuppressive drug, tacrolimus, has been reported to promote nerve recovery in animal models. However, its repeated dosing comes with risks of systemic malignancies and opportunistic infections. Therefore, drug delivery approaches for locally sustained release can be designed to overcome this issue and reduce systemic complications. We developed a mixed thermosensitive hydrogel (poloxamer (PLX)-poly(l-alanine-lysine with Pluronic F-127) for the time-dependent sustained release of tacrolimus in our previous study. In this study, we demonstrated that the hydrogel drug degraded in a sustained manner and locally released tacrolimus in mice over one month without affecting the systemic immunity. The hydrogel drug significantly improved the functional recovery of injured sciatic nerves as assessed using five-toe spread and video gait analysis. Neuroregeneration was validated in hydrogel–drug-treated mice using axonal analysis. The hydrogel drug did not cause adverse effects in the mouse model during long-term follow-up. The local injection of encapsulated-tacrolimus mixed thermosensitive hydrogel accelerated peripheral nerve recovery without systemic adverse effects.Keywords
Funding Information
- Ministry of Science and Technology, Israel (109-2314-B-182-074, 109-2314-B-182A-056-MY3, 110-2314-B-182A-137-MY3, CMRPG1L0041, CMRPG3M0281, CMRPG3M0282)
- Chang Gung Medical Foundation (109-2314-B-182-074, 109-2314-B-182A-056-MY3, 110-2314-B-182A-137-MY3, CMRPG1L0041, CMRPG3M0281, CMRPG3M0282)
This publication has 56 references indexed in Scilit:
- Early steps of microglial activation are directly affected by neuroprotectant FK506 in both in vitro inflammation and in rat model of strokeJournal of Molecular Medicine, 2012
- Clinical Strategies to Enhance Nerve Regeneration in Composite Tissue AllotransplantationHand Clinics, 2011
- Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomesInternational Journal of Pharmaceutics, 2011
- Tacrolimus-Induced Neutropenia in Renal Transplant RecipientsClinical Journal of the American Society of Nephrology, 2011
- What Is the Optimal Value of the g-Ratio for Myelinated Fibers in the Rat CNS? A Theoretical ApproachPLOS ONE, 2009
- Hydrogel biomaterials: A smart future?Biomaterials, 2007
- Hand transplantation: Comparisons and observations of the first four clinical casesMicrosurgery, 2000
- Rescue therapy with tacrolimus (FK 506) in renal transplant recipients -a Scandinavian multicenter analysisTransplant International, 1997
- Rescue therapy with tacrolimus (FK 506) in renal transplant recipients —a Scandinavian multicenter analysisTransplant International, 1996
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991